| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.47 | 2e-21 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-21 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-18 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-16 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-15 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-14 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-14 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-13 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-11 |